Mylan Prilosec Litigation Ongoing; Omeprazole Sales Up In Fourth Quarter
This article was originally published in The Tan Sheet
Executive Summary
Mylan Labs continues to pursue litigation against Procter & Gamble over the marketing of Prilosec OTC as the company attempts to shield its growing Rx omeprazole business from OTC competition